Reserpine
Sponsors
National Heart, Lung, and Blood Institute (NHLBI), National Institute on Drug Abuse (NIDA), Mayo Clinic, University of Alabama at Birmingham, Zeng Changhao
Conditions
Amphetamine-Related DisordersCardiovascular DiseasesCerebrovascular DisordersCocaine-Related DisordersHeart DiseasesHypertensionPulmonary Artery HypertensionRefractory Hypertension
Phase 1
A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1
NCT00267657
Start: 2004-01-31End: 2004-11-30Target: 30Updated: 2017-01-11
A Study of Stellate Ganglion Block and / or Reserpine in Group 2 Pulmonary Hypertension
WithdrawnNCT02684786
Start: 2016-07-31End: 2016-07-31Updated: 2019-05-22
Phase 2
Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study)
CompletedNCT00000499
Start: 1980-09-30End: 1983-05-31Updated: 2013-11-26
Reserpine for the Treatment of Cocaine Dependence - 1
CompletedNCT00033033
Start: 2001-07-31End: 2003-05-31Target: 140Updated: 2017-01-12
Mechanisms of Refractory Hypertension (Reserpine)
CompletedNCT03223272
Start: 2015-07-23End: 2020-01-31Updated: 2021-11-30